People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Beta Bionics, Inc | — | Other Health Care | Series C | $277.5M | $1.0B | 2023 |
Francesco T. Draetta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Francesco T. Draetta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Carney | 1 | 6 |
| Thomas A. Fitzgerald | 1 | 3 |
| Gilbert Clarke | 1 | 3 |
| Sean D. Carney | 1 | 3 |
| Martha Aronson | 1 | 2 |
| Christy Jones | 1 | 2 |
| Gilad T. Glick | 1 | 1 |
| Westley T. Dupray | 1 | 1 |
| Parker T. Cassidy | 1 | 1 |
| Gibb Clarke | 1 | 1 |
| Marcie Cain | 1 | 1 |
| Finny Kuruvilla | 1 | 1 |
| Beth Brooke | 1 | 1 |
| Michael Pereira | 1 | 1 |
| Veena Rao | 1 | 1 |
| Jeff Hitchcock | 1 | 1 |
| Edward Raskin | 1 | 1 |
| Mike Roskino | 1 | 1 |
| Agustin Mohedas | 1 | 1 |
| Serafina Raskin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.